Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Synopsys

Synopsys Stock Falls On Weak Guidance After Mixed Quarterly Report

Chip design software maker Synopsys delivered better-than-expected earnings on in-line sales for its fiscal first quarter.

Investors Business Daily

Nasdaq Enters Rare "Power Trend"; Here Are 3 Ways To Profit

What is the Nasdaq power trend and how can you profit from this rare market occurrence?

Investors Business Daily

Here's Why The Stock Market Should End The Year Higher; Tesla Leads These Potential Winners

Investors may be worried after the brutal stock market action of 2022. But stocks should go higher, with Tesla stock and Cisco among potential big winners.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Synopsys Stock Closes In On Key Threshold After Naming CFO

A Relative Strength Rating upgrade for Synopsys stock shows improving technical performance. Will it continue?

Investors Business Daily

Why These Chip Design Stocks Just Got Fresh Buy Ratings

Cadence Design Systems and Synopsys should benefit from continued strong demand for their chip design tools for years to come, an analyst says.

Investors Business Daily

After Taking A Whupping, AAPL Leads 29 Tech Stocks Back In Demand

AAPL stock among 29 tech plays in demand among the best mutual funds as the technology sector emerges from exile.

Investors Business Daily

Analysts Like These Semiconductor Stocks Amid Rising Chip Inventories

With chip stocks facing headwinds like rising inventories and slowing demand in certain segments, Wall Street sees some bright spots.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Falls After Key Economic Data; BBBY Stock Plunges 28%

The Dow Jones Industrial Average fell Thursday after key economic data. BBBY stock dived after RC Ventures disclosed a plan to sell shares.

Investors Business Daily

Dow Jones Futures Rise: Costco Rival Breaking Out, Time To Bite Into Apple Stock?

The market rally fell Wednesday despite dovish Fed minutes. Apple hit a buy area. Should you bite? BBBY stock dived late.

Investors Business Daily

Synopsys Quarterly Earnings, Revenue Beat Wall Street Estimates

Synopsys stock jumped after reporting quarterly earnings late Wednesday that beat estimates on the top and bottom lines.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2022

Benzinga

Synopsys (SNPS) To Report Q3 Earnings: What's In Store?

Synopsys (NASDAQ: SNPS) is slated to report third-quarter fiscal 2022 results on Aug 17.

Benzinga

Synopsys Stock Climbs Into Buy Zone With Earnings Due Next Week

IBD 50 member Synopsys (SNPS) is trading within a buy range with its next quarterly report on tap for Aug. 17. It's trading approximately 1% above a 377.70 buy point from a first-stage consolidation. Volume is trending lower today after two days of up volume. Understand that buying a stock…

Investors Business Daily

What Happens To The S&P 500 This Month? 7 Stocks Are The Best

August isn't usually a great month for the S&P 500. But that doesn't mean you need to bail out.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Gains Fade; Tesla Up After Elon Musk Issues This Twitter Challenge; AMC Stock Rockets

The Dow Jones gave up gains. Tesla stock gained after CEO Elon Musk issued a challenge to Twitter. AMC popped as meme stocks rallied.

Investors Business Daily

Synopsys Stock Near Buy Zone With Earnings Due Very Soon

Synopsys is forming a base and near a possible buy point ahead of its next quarterly earnings report, expected on or around Aug. 17.

Investors Business Daily

Cadence Design Systems Rises After Beat-And-Raise Report

Cadence Design Systems, a maker of electronic systems design software, late Monday beat Wall Street's targets for the second quarter.

Investors Business Daily

Synopsys, IBD Stock Of The Day, Approaching Buy Point As It Outperforms

Synopsys is the IBD Stock Of The Day as the chip design software maker climbs amid strong demand for its tools. SNPS stock is approaching a buy point.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures: Stock Market Rally Breaks Key Resistance; Netflix Jumps On Subscriber Data

The stock market rally broke above key levels Tuesday, but faces several challenges. Netflix subscribers fell less than feared. Tesla earnings loom.

Benzinga

Infosys (INFY) Boosts Digital Portfolio With BASE Life Buyout

Infosys (NYSE: INFY) recently announced that it has signed a definitive agreement to acquire the Denmark-based technology and consulting firm in the life sciences industry – BASE Life Science.

Benzinga

Here's How Much $100 Invested In Synopsys 10 Years Ago Would Be Worth Today

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.1% on an annualized basis producing an average annual return of 25.9%. Currently, Synopsys has a market capitalization of $46.08 billion.

Investors Business Daily

Chip Design Firms Upgraded As Chipmakers Downgraded

A Wall Street firm downgraded several semiconductor stocks as the outlook for chip sales ebbs, but it upgraded two chip design firms.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2022

Upgrades

Benzinga

Walmart And 3 Other Stocks Insiders Are Selling

US stock futures traded slightly higher this morning on Monday after recording sharp gains in the previous session. Investors, meanwhile, focused on some notable insider trades.

Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,900 Today

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 5 years by 22.62% on an annualized basis producing an average annual return of 31.23%. Currently, Synopsys has a market capitalization of $44.42 billion.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.